Connect With Us: Follow Us on Twitter Our YouTube Channel Contact Us Our Social Media



PRESS ROOM

ADAP Advocacy issued the following press releases:


ADAP Advocacy Calls for More Awareness on Counterfeit Medicines

Counterfeit pill availability in the United States is increasing, including recent incidents involving HIV medications

WASHINGTON, D.C. (September 13, 2023) - WASHINGTON, D.C. – ADAP Advocacy, in collaboration with the Partnership for Safe Medicines (PSM), is calling for more awareness over counterfeit medicines in the United States. Data recently shared in the MMWR [Morbidity and Mortality Weekly Report] highlights a growing problem, which is potentially contributing to overdose deaths. Aside from some high-profile cases involving criminal enterprises pushing fake HIV medications, counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Submits Public Comment on 340B Program

Senator’s Bipartisan Working Group on 340B issued request for information on how to improve accountability and transparency

WASHINGTON, D.C. (July 27, 2023) - WASHINGTON, D.C. – ADAP Advocacy, in collaboration with the Community Access National Network (CANN), submitted public comment in response to the Request for Information (RFI) issued by the Senator’s Bipartisan 340B Working Group seeking feedback on the 340B Drug Pricing Program. The recommendations submitted to the working group focus on returning the 340B Program to its legislative intent, rather than the program’s current trajectory which largely benefits providers over patients.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Rebranded to ADAP Advocacy

New Brand Reflects Renewed Focus on AIDS Drug Assistance Programs

WASHINGTON, D.C. (July 24, 2023) - The ADAP Advocacy Association today announced it has been rebranded to “ADAP Advocacy”, a move reflecting the organization’s renewed focus on the AIDS Drug Assistance Program (“ADAP”).The legal entity will remain the ADAP Advocacy Association.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


JOINT STATEMENT ON TRAVEL ADVISORY IN THE STATE OF FLORIDA FOR PEOPLE LIVING WITH HIV

On behalf of the ADAP Advocacy Association and Community Access National Network (CANN)

WASHINGTON, D.C. (May 24, 2023) - The ADAP Advocacy Association (aaa+®) and the Community Access National Network (CANN) issued the following joint statement in response to a series of hateful bills passed by the Florida Legislature and signed into law by Governor Ron DeSantis. The ADAP Advocacy Association and CANN are hereby adjoined to the formal travel advisories issued by the NAACP, League of United Latin American Citizens, and Equality Florida – calling Florida 'hostile' to Black Americans, people of color and LGBTQ+ individuals. Both organizations also are concerned Florida's politics is now hostile toward people living with HIV.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Releases 2022 Annual Report

Highlighting its Commitment to Access, Information & Participation

WASHINGTON, D.C. (April 25, 2023) - The ADAP Advocacy Association (aaa+®) today released its 2022 Annual Report – which highlights the organization’s ongoing commitment to access, information and participation for patient advocacy designed to promote and protect the AIDS Drug Assistance Program ("ADAP"). The report is shared using an infographic format to capture the previous year's highlights.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Joins Groups Supporting 'Safe Step Act'

Legislation puts common sense guidelines around insurance industry practice of "step therapy"

WASHINGTON, D.C. (April 18, 2023) - The ADAP Advocacy Association (aaa+®) today announced it joined over 200 patient and health care provider groups from across the country applauding the reintroduction of the legislation aimed at putting reasonable parameters around the insurance industry’s "step therapy" or "fail first" cost containment protocols. The Safe Step Act mirrors legislation passed in more than three dozen states across the country. When passed into law the legislation will bring similar patient protections to employer health plans that are regulated on the federal level.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Tackles Counterfeit HIV Medicines

ADAP Advocacy Association Tackles Counterfeit HIV Medicines

WASHINGTON, D.C. (April 6, 2023) - The ADAP Advocacy Association (aaa+®) participated in a digital policy briefing hosted by the Partnership for Safe Medicines (PSM) on recent supply chain breaks involving counterfeit, misbranded and substandard HIV medications. The digital policy briefing is part of the comprehensive PSM 118th Congress Counterfeit Drug Briefing – which also encompasses the dangers behind drug importation and online pharmacies.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Joins Alliance to Save America’s 340B Program

Alliance reinforces the urgency for action today to ensure the long-term viability of the program for tomorrow

WASHINGTON, D.C. (March 28, 2023) - The ADAP Advocacy Association (aaa+®) today announced it has joined the Alliance to Save America’s 340B Program (ASAP 340B), which is a partnership of community health centers, patient, provider, and consumer advocates, and leaders from the biopharmaceutical industry working to ensure the 340B program supports true safety-net providers and the communities they serve. ASAP 340B reflects a growing chorus calling for accountability and transparency reforms.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Joins Amicus Brief to Protect Patients

Amicus Brief filed in suit to end policy that prohibits copay assistance from counting toward patients’ out-of-pocket spending

WASHINGTON, D.C. (February 23, 2023) - The ADAP Advocacy Association (aaa+®) today announced it joined 29 patient, provider, and consumer organizations representing a wide range of illnesses and health conditions filing an amicus brief in support of a case brought against the U.S. Department of Health and Human Services by the HIV+Hepatitis Policy Institute, the Diabetes Leadership Council, the Diabetes Patient Advocacy Coalition, and three patients.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC


ADAP Advocacy Association Announces 2023 Health Fireside Chats

Retreats designed to assemble key stakeholder groups to discuss pertinent issues facing people living with HIV/AIDS and other chronic health conditions

WASHINGTON, D.C. (January 25, 2023) - The ADAP Advocacy Association (aaa+®) today announced its 2023 Health Fireside Chats.

Download the Press Release:  Google Docs Viewer PDF | Google Docs Viewer DOC

 


Past Press Releases: [2022] · [2021] · [2020] · [2019] · [2018] · [2017] · [2016] · [2015] · [2014] · [2013] · [2012] · [2011] · [2010] · [2009]

 

Donations secured by PayPal
Support our Scholarship Fund